Foley Partner J. Mark Waxman will be speaking at the American Conference Institute’s (ACI) “Government Healthcare Fraud Enforcement” conference, June 19 – 20, 2007 at the Hilton Alexandria Mark Center in Alexandria, VA.
Topic: False Claims Act Investigations, Litigation, and Corrective Action: Emerging Theories, Trends, and Legislative Developments
Date: Wednesday, June 20, 2007
Time: 9:15 a.m. – 10:45 a.m.
- Preparing for the operational and litigation management issues that arise as the result of whistleblower suits
- Dealing simultaneously with government and whistleblower counsel
- Maintaining good management-employee relationships during whistleblower litigation
- Assessing the impact of Rockwell International v. U.S. ex rel. Stone on the concept of “original source” on healthcare fraud and abuse litigation
- Defending providers for alleged violations of the FCA where no conduct violates Medicare rules “scheme to defraud”
- Identifying appropriate whistleblower protections and understanding the employment law issues that arise in the context of a whistleblower suit
Moderator: Gregory M. Luce, Co-Chair, Health Care Practice Group, Jones Day
Speakers:
- J. Mark Waxman, Chair, Health Care Industry Team, Foley & Lardner LLP
- Jonathan Diesenhaus, Partner, Hogan & Hartson LLP, Former Senior Trial Counsel, Civil Division, USDOJ
Related Insights
21 October 2024
Events
Legal Overview of the BIOSECURE Act
Foley special counsel John Strom is speaking in the Association for Accessible Medicine’s GRx+Biosims 2024 conference in a panel titled “Legal Overview of the BIOSECURE Act” on October 21.
04 October 2024
Innovative Technology Insights
Decoding California’s Recent Flurry of AI Laws
Governor Newsom signed over 18 AI-related bills into law during September, impacting numerous industries.
17 October 2024
Events
Top Compliance Considerations when Commercializing in the U.S.
Kyle Faget and Nathan "Nate" Beaver, co-chair of Foley's Medical Device and Equipment Area of Focus within the firm's Health Care & Life Sciences Sector, invite you to join us for a webinar on the compliance considerations you need to know when you are commercializing your medical device products in the U.S.